Cross-reactivity in β-Lactam Allergy

Department

Research

Document Type

Article

Publication Title

The Journal Of Allergy And Clinical Immunology. In Practice

Abstract

β-Lactam drugs (penicillins, amoxicillin, and cephalosporins) account for 42.6% of all severe drug-induced anaphylaxis. In this review, we focus on clinically significant immunologic cross-reactivity in patients with confirmed penicillin allergy to cephalosporins, and the structural involvement of the R and R chemical side chains of the cephalosporins causing IgE-mediated cross-reactivity with penicillin and other cephalosporins. Skin tests predict IgE-mediated reactions and showed cross-reactivity between penicillins and early generation cephalosporins that shared side chains, but confirmatory challenge data are lacking. Later-generation cephalosporins, which have distinct side chains, do not have any skin test cross-reactivity with penicillin/amoxicillin. There is debate as to the involvement of R side chains as the antigenic determinants that cause IgE-mediated hypersensitivity with various cephalosporins. Avoidance of cephalosporins, when they are the drug of choice in a penicillin-allergic individual, results in significant morbidity that outweighs the low risk of anaphylaxis. We conclude that there is ample evidence to allow the safe use of cephalosporins in patients with isolated confirmed penicillin or amoxicillin allergy.

First Page

72

Last Page

81.e1

DOI

10.1016/j.jaip.2017.08.027

Volume

6

Issue

1

Publication Date

1-1-2018

Medical Subject Headings

Allergens (immunology); Animals; Anti-Bacterial Agents (immunology, therapeutic use); Cephalosporins (immunology); Cross Reactions; Drug Hypersensitivity (immunology); Epitopes; Humans; Immunoglobulin E (metabolism); Penicillins (immunology); Skin Tests; beta-Lactams (immunology, therapeutic use)

PubMed ID

29017833

Link to Full Text

Share

COinS